CSIMarket
 
Orthopediatrics Corp  (NASDAQ: KIDS)
 
Price: $22.4100 $-0.18 -0.797%
Day's High: $22.559999465942383 Week Perf: -3.86 %
Day's Low: $ 21.93 30 Day Perf: -1.84 %
Volume (M): 129,500 52 Wk High: $ 26.74
Volume (M$): $ 0 52 Wk Avg: $18.42
Open: $22.29 52 Wk Low: $14.42



 Market Capitalization (Millions $) 531
 Shares Outstanding (Millions) 24
 Employees 602
 Revenues (TTM) (Millions $) 242
 Net Income (TTM) (Millions $) -40
 Cash Flow (TTM) (Millions $) -21
 Capital Exp. (TTM) (Millions $) 9

Business Description


OrthoPediatrics Corp. is a medical device company that focuses on designing and manufacturing orthopedic implants, instruments, and surgical techniques that are specifically designed for children. Founded in 2006, OrthoPediatrics Corp. is headquartered in Warsaw, Indiana with offices in the United Kingdom, Australia, and Japan. The companyes mission is to improve the lives of children with musculoskeletal disorders and injuries, by providing innovative orthopedic solutions that cater to their unique needs.

OrthoPediatrics Corp. offers a wide range of pediatric-specific orthopedic products, including plates, screws, nails, and intramedullary rods. These devices are used to treat various conditions such as limb deformities, fractures, spinal disorders, and sports injuries. The company also provides surgeons with specialized instrument sets that are designed for pediatric procedures, which aid in enhancing surgical outcomes and reducing operating times.

A key differentiating factor of OrthoPediatrics Corp. is its dedication to advancing orthopedic care for children. The company has partnered with leading pediatric orthopedic surgeons and institutions to develop new surgical techniques and technologies that address the unique challenges of treating pediatric patients. This includes the development of the TELEMED, a remote surgical system that enables surgeons to provide real-time consultations, training, and support to colleagues in other locations.

OrthoPediatrics Corp. has received several accolades for its innovative products and commitment to improving orthopedic care for children. In 2017, the company was named the fastest-growing public company in Indiana by the Indianapolis Business Journal. OrthoPediatrics Corp. was also awarded the Medical Device Engineering Breakthrough Award in 2018 by the Medical Design & Outsourcing magazine.

In summary, OrthoPediatrics Corp. is a medical device company that specializes in designing and manufacturing orthopedic products that cater to the unique needs of pediatric patients. With a focus on innovation and a commitment to advancing pediatric orthopedic care, OrthoPediatrics Corp. has established itself as a leader in this specialized field.


   Company Address: 2850 Frontier Drive Warsaw 46582 IN
   Company Phone Number: 268-6379   Stock Exchange / Ticker: NASDAQ KIDS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EW   -0.34%    
GMED   -5.64%    
MDT        3.22% 
SYK   -8.33%    
TFX   -0.94%    
ZBH   -2.81%    
• View Complete Report
   



Product Service News

OrthoPediatrics Crafting New Paths in Pediatric Orthopedics Amid Financial Resurgence,

Published Thu, Nov 13 2025 12:52 PM UTC

Marching Forward in Pediatric Orthopedics: OrthoPediatrics Unveils New Bracing Solutions Amidst Financial Recovery In the heart of Warsaw, Indiana, OrthoPediatrics Corp. continues to carve a niche in pediatric orthopedics with an unwavering commitment to innovation and progress. On November 13, 2025, the company proudly announced the expansion of its Specialty Bracing portfo...

Product Service News

OrthoPediatrics Corp. Secures FDA Approval for Pediatric System, Faces Market Hurdles,

Published Wed, Oct 29 2025 5:02 PM UTC

OrthoPediatrics Corp. Achieves FDA Approval for New Pediatric Orthopedic System Amidst Market Challenges Warsaw, Ind., Oct. 28, 2025 OrthoPediatrics Corp. (Nasdaq: KIDS), a leader in pediatric orthopedic medical devices, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its 3P Pediatric Plating Platform Small-Mini System. This system...

Product Service News

Strategic Bracing OrthoPediatrics Pursuit of Growth amid Financial Challenges,

Published Tue, Nov 26 2024 9:05 PM UTC

OrthoPediatrics Corp. Braces for Growth with DF2 Innovations In the niche yet steadily expanding market of pediatric orthopedics, OrthoPediatrics Corp. has unveiled significant enhancements to its DF2 Brace a cornerstone product of their Specialty Bracing business. This development underscores the company’s commitment to its mission: advancing pediatric orthopedic care thr...

Product Service News

OrthoPediatrics Corp. Launches Enabling Technologies Division Pioneering Innovations in Pediatric Orthopedics

Published Thu, Sep 12 2024 11:05 AM UTC

In a strategic move poised to reshape the landscape of pediatric orthopedic care, OrthoPediatrics Corp. has officially announced the launch of its Enabling Technologies Division. The initiative aims to develop cutting-edge solutions that enhance surgical efficiencies and improve patient outcomes in children with musculoskeletal conditions. Founded with a mission to address t...

Financing Agreement

OrthoPediatrics Corp. Secures $100 Million in Capital through Private Financing

Published Mon, Aug 5 2024 8:10 PM UTC



OrthoPediatrics Corp., a leading orthopedic medical device company specializing in pediatric orthopedics, has recently announced a major private financing initiative. The company aims to raise up to $100 million in capital through a combination of term loans and a private placement of convertible notes. This infusion of funds will be instrumental in driving the com...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.20
Price to Sales (Expected) -
Price to Book 1.57
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.1
Working Capital Ratio 5.53
Leverage Ratio (MRQ) 0.47
Total Debt to Equity 0.3
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.68 $
Revenues (TTM) 10.21 $
Cash Flow (TTM) -
Cash 2.06 $
Book Value 14.3 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 401,643
Net Income per Employee (TTM) -65,907
Receivable Turnover Ratio (TTM) 4.53
Inventory Turnover Ratio (TTM) 0.49
Asset Turnover Ratio (TTM) 0.48

Profitability Ratios Current
Gross Margin (MRQ) 74.31 %
Operating Margin (MRQ) -14.27 %
Net Margin (MRQ) -18.3 %
Net Cash Flow Margin (MRQ) -12.63 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Orthopediatrics's Segments
U S    77.6 % of total Revenue
International    24.07 % of total Revenue
Trauma and deformity    73.72 % of total Revenue
Scoliosis    26.45 % of total Revenue
Sports medicine other    1.5 % of total Revenue

  Orthopediatrics Outlook

On August 5 2024 the Orthopediatrics provided following guidance

OrthoPediatrics Corp. has released its financial results for the second quarter of 2024, showcasing a remarkable 33% increase in revenue compared to the same period last year. This impressive growth underscores the company's strong performance and solidifies its position in the pediatric orthopedic market.

In this latest report, OrthoPediatrics Corp. also reaffirmed its revenue guidance for the full year 2024, indicating confidence in its business strategy and market potential. While specific revenue figures or ranges were not disclosed, the company's leadership remains optimistic about achieving its financial targets.

Overall, the record revenue reported for the second quarter not only reflect...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.